Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prodrugs activated by plasmin and their use in cancer chemotherapy

Prodrugs activated by plasmin and their use in cancer chemotherapy

US Patent 7402556 · Granted Jul 22, 2008

Estimated economic value: $14,818,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Minimally toxic prodrugs2020
Minimally toxic prodrugs2018
Predictive biomarker for cancer treatment with ADCC-enhanced antibodies2016
Process for functionalization of unsaturated compounds2015
Enzyme-cleavable prodrug compounds2011
Enzyme-cleavable prodrug compounds2011
Tumor-activated prodrug compounds and treatment2011
Prodrugs activated by plasmin and their use in cancer chemotherapy2011
Prodrugs activated by plasmin and their use in cancer chemotherapy2011
Prodrugs activated by plasmin and their use in cancer chemotherapy2011
Tripeptide prodrug compounds2010
Tripeptide prodrug compounds2010